World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
133
Citations
111341
World Ranking
2173
National Ranking
1228

Research.com Recognitions

  • 1942 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Bruce E. Johnson is affiliated with Harvard University in the United States and has made extensive contributions across several fields within medicine and molecular biology. Their primary research areas include oncology, pulmonary and respiratory medicine, molecular biology, cancer research, and radiology, nuclear medicine, and imaging.

Johnson's research topics cover a broad range of cancer-related fields, notably:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Single-cell and spatial transcriptomics
  • Lung Cancer Research Studies

The scientist has published numerous articles in high-impact journals and is frequently published in venues such as:

  • Cancer Research
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Medicine

Among their recent papers are:

  • "A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors," 2020, Nature Medicine
  • "Spatially organized multicellular immune hubs in human colorectal cancer," 2021, Cell
  • "The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution," 2020, Cell
  • "Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer," 2021, Cell
  • "A single-cell landscape of high-grade serous ovarian cancer," 2020, Nature Medicine

Their collaboration network includes frequent co-authors such as:

  • Mark M. Awad
  • Lynette M. Sholl
  • Biagio Ricciuti
  • Joao V. Alessi
  • Scott J. Rodig

Johnson has also contributed to book publications, including "Essential Visual Studio 2019" published by Apress eBooks in 2020.

The main academic fields represented in their work are medicine and biochemistry, genetics, and molecular biology, with a combined publication count indicating a significant focus on biomedical research.

They have been recognized by professional societies through awards such as:

  • Fellow of the American Association for the Advancement of Science (AAAS), 1942
  • Member of the Association of American Physicians

Best Publications

  • EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

    J. Guillermo Paez;Pasi A. Jänne;Pasi A. Jänne;Jeffrey C. Lee;Sean Tracy

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Jeffrey A. Engelman;Kreshnik Zejnullahu;Tetsuya Mitsudomi;Youngchul Song

  • EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib

    Susumu Kobayashi;Titus J. Boggon;Tajhal Dayaram;Pasi A. Jänne

  • A cell cycle regulator potentially involved in genesis of many tumor types

    Alexander Kamb;Nelleke A. Gruis;Jane Weaver-Feldhaus;Qingyun Liu

  • Comprehensive genomic characterization of squamous cell lung cancers

    Peter S. Hammerman;Doug Voet;Michael S. Lawrence;Douglas Voet

  • Somatic mutations affect key pathways in lung adenocarcinoma

    Li Ding;Gad Getz;David A. Wheeler;Elaine R. Mardis

  • Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

    Arindam Bhattacharjee;William G. Richards;Jane Staunton;Cheng Li

  • Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

    David A. Eberhard;Bruce E. Johnson;Lukas C. Amler;Audrey D. Goddard

  • Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing

    Marcin Imielinski;Alice H. Berger;Alice H. Berger;Peter S. Hammerman;Peter S. Hammerman;Bryan Hernandez

  • TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

    Roy S. Herbst;Diane Prager;Robert Hermann;Lou Fehrenbacher

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

    Shohei Koyama;Esra A. Akbay;Yvonne Y. Li;Grit S. Herter-Sprie

  • A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

    Livnat Jerby-Arnon;Parin Shah;Michael S. Cuoco;Christopher Rodman

  • Characterizing the cancer genome in lung adenocarcinoma

    Barbara A. Weir;Barbara A. Weir;Michele S. Woo;Gad Getz;Sven Perner;Sven Perner

  • LKB1 modulates lung cancer differentiation and metastasis

    Hongbin Ji;Matthew R. Ramsey;D. Neil Hayes;Cheng Fan

  • Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

    David Planchard;Egbert F Smit;Harry J M Groen;Julien Mazieres

  • First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

    Lecia V. Sequist;Renato G. Martins;David Spigel;Steven M. Grunberg

  • The BATTLE Trial: Personalizing Therapy for Lung Cancer

    Edward S. Kim;Roy S. Herbst;Ignacio Ivan Wistuba;Jiun-Kae Jack Lee

  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Priscilla K. Brastianos;Scott L. Carter;Scott L. Carter;Sandro Santagata;Sandro Santagata;Daniel P. Cahill

Frequent Co-Authors

Pasi A. Jänne
Pasi A. Jänne Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University
John D. Minna
John D. Minna The University of Texas Southwestern Medical Center
Joseph M. Pilewski
Joseph M. Pilewski University of Pittsburgh
Mizuki Nishino
Mizuki Nishino Harvard University
Adi F. Gazdar
Adi F. Gazdar The University of Texas Southwestern Medical Center
Neal I. Lindeman
Neal I. Lindeman Brigham and Women's Hospital
Daniel C. Ihde
Daniel C. Ihde National Institutes of Health
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Paul A. Bunn
Paul A. Bunn University of Colorado Boulder

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in the medical field can open doors to rewarding healthcare careers without the time or costs associated with a traditional MD. Many students are now turning to online programs for greater flexibility and affordability.

Specializing in health informatics is a fast-growing option with high demand for professionals who can manage electronic health records and data systems. For those interested in the administrative side of healthcare, understanding how much does it cost to become a medical coder can help you evaluate if this in-demand field is right for you.

Nursing remains one of the most popular career paths, and online programs make it more accessible than ever. If you're looking at becoming a nurse practitioner, consider researching the cheapest online fnp programs to balance quality education and tuition costs. Similarly, it's important to understand how much is online nursing school to properly plan your investment in a nursing degree.

Exploring these related online degrees can help you find the right fit for your interests, budget, and career goals in the evolving world of healthcare.

Best Scientists Citing Bruce E. Johnson

Trending Scientists

Recently Published Articles